NextCell Pharma AB

ISIN SE0022240800Filings at the FI

At a glance

Most recent filing on June 2, 2025 — an option exercise by Hangethe Consulting AB on May 30, 2025.

We hold 2 visible filings, going back to May 30, 2025.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

All 2 shown

  • Hangethe Consulting AB Closely associated: Chief financial officer
    298,440 sharesOption exercise
    TradedMay 30, 2025FiledJun 2, 2025
  • Patrik Fagerholm Chief financial officer
    1,320 sharesOption exercise
    TradedMay 30, 2025FiledJun 2, 2025